Developer docs
API playgroundTry for free, no card

Search company profiles

VB-Tech

Full company profile

uuid0003dvl

Namestring
VB-Tech
Legal namestring
VB Tech S.A.S.
Company typeenum
Private
Founded yearint
2021
Descriptiontext

VB Tech S.A.S., headquartered in Aix-en-Provence, France, develops patient-specific digital brain twin technology for neurological and neurosurgical applications. The company's flagship product, BrainXplore, is a browser-based platform that ingests multimodal neuroimaging data (MRI, DTI, EEG, MEG, SEEG) and produces biophysically grounded whole-brain simulations using its exclusively licensed core engine, The Virtual Brain (TVB). Its lead clinical module, VEP (Virtual Epileptic Patient), provides clinical decision support for drug-resistant epilepsy by identifying epileptogenic zones with a 29% improvement over standard of care and enabling virtual surgery planning; the technology is currently being validated in the EPINOV trial, the largest epilepsy-surgery clinical study to date (13 centers, 356 patients), with an FDA submission in progress.

The company operates a Hub-model distribution strategy: leading academic medical centers (APHM Marseille as Hub #0, UPMC Pittsburgh as Hub #1, UC Davis as Hub #3) install BrainXplore on-premises, receive training, and serve as clinical reference sites for research and investigational use. The current revenue posture is largely pre-commercial: Hubs receive free research access, monetizable streams are expected to come from software subscriptions, clinical module licensing (VEP), pharma partnership services for Alzheimer/Parkinson's/M/S/schizophrenia, and the BrainXplore Clinical Fellowship Program. Leadership combines academic founders (CSO Prof. Viktor Jirsa, EPINOV lead Prof. Fabrice Bartolomei) with industrial scale-up operators (CEO Serge De Senti from January 2026, Deputy CEO Jean-Marc Ferrier, CTO Eric Guiffard, CGO Philippe Schulz), and the company has only one disclosed external capital event — a $519,167 round from Rise Partners in January 2025.

Short descriptiontext

VB Tech (VB Tech S.A.S.) is a French deep-tech company developing patient-specific digital brain twins via its BrainXplore platform, serving academic neurosurgery centers and pharmaceutical partners — initially targeting drug-resistant epilepsy through its clinically validated VEP module.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMarseille, France
HQ citystring
Marseille
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital brain twin, neurological simulation software, epilepsy surgery planning, computational neuroscience platform, patient-specific brain modeling
Industry1 code
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Computer Integrated Systems Design7373
Product category
Computational Neuroscience Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Software Platform Licensing (BrainXplore)
TypeSubscription Recurring
Description

BrainXplore platform offered for research, education, and investigational clinical studies. Hubs receive free access for research. Revenue model likely centers on software licensing/subscription for clinical deployment post-regulatory validation.

virtualbraintech.com
2Clinical Module Licensing (VEP Module)
TypeLicensing Royalties
Description

VEP (Virtual Epileptic Patient) module designed as a clinical decision-support tool for neurosurgical planning in drug-resistant epilepsy. Expected to generate revenue through clinical licensing as regulatory approval is obtained.

virtualbraintech.com
3Pharmaceutical Industry Partnerships
TypeProfessional Services
Description

Clinical modules for other brain diseases (Alzheimer's, Parkinson's, M/S, Schizophrenia) to be developed in partnership with pharmaceutical industry to support precision drug development.

virtualbraintech.com
4Clinical Fellowship Program
TypeProfessional Services
Description

BrainXplore Clinical Fellowship Program — an immersive experience for neurologists, neurosurgeons, and researchers, with 5 fellowship slots remaining through end of 2026.

virtualbraintech.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1VEP – Virtual Epileptic Patient™
Description

Clinical decision-support module for patients with drug-resistant epilepsy that simulates the propagation of epileptic activity across the brain network using patient-specific neuroimaging and intracranial EEG data.

virtualbraintech.com
+1 more record
Core offering1 text field

VB Tech provides the BrainXplore platform, a browser-based system that generates patient-specific digital brain twins from multimodal neuroimaging data (MRI, DTI, EEG, SEEG, MEG) to simulate whole-brain dynamics. The platform's first clinical module, the Virtual Epileptic Patient (VEP), supports surgical planning for drug-resistant epilepsy by identifying epileptogenic zones and enabling virtual testing of resection strategies before surgery. Additional clinical modules for Alzheimer's, Parkinson's, multiple sclerosis, and schizophrenia are in development in partnership with pharmaceutical companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 29% improvement in identification of epileptogenic zones vs standard methods (retrospective study on 53 patients)
+4 more records
Product overview1 text field

VB Tech provides a modular brain simulation platform centered on BrainXplore, a browser-based platform that generates patient-specific digital brain twins from multimodal neuroimaging data. The core Virtual Brain Twin technology simulates whole-brain dynamics. The VEP (Virtual Epileptic Patient) module targets drug-resistant epilepsy for surgical planning. Additional modules for Alzheimer's, Parkinson's, M/S, and schizophrenia are in development in partnership with pharmaceutical industry for precision drug development.

Product and service2 records
1BrainXplore Platform
CategoryDigital Brain Twin Platform
Description

Browser-based digital brain twin platform that generates patient-specific virtual brain models from multimodal neuroimaging data. Provides automated preprocessing, personalized whole-brain simulations, advanced inference modules, and an interactive 3-D viewer for clinicians and researchers in neurology and neuroscience.

2VEP - Virtual Epileptic Patient Module
CategoryClinical Decision Support Software
Description

Clinical decision-support module for drug-resistant epilepsy patients that uses patient-specific neuroimaging and intracranial EEG (SEEG) data to simulate epileptic activity propagation across the brain network. Identifies epileptogenic zones by comparing simulated seizure dynamics to recorded data and enables virtual testing of resection strategies before surgery.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-03-07
Description

UPMC Pittsburgh is Hub #1, an official BrainXplore ambassador. VB Tech installed the BrainXplore platform and trained clinicians and researchers to use it in daily workflows. Led by Jorge A. González-Martínez, MD, PhD. Represents VB Tech's US market entry.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-03-07
Description

UC Davis is Hub #3, an official BrainXplore ambassador. VB Tech installed the BrainXplore platform and trained clinicians and researchers to use it in daily workflows. Led by Nigel Paul Pedersen, MD. Second US-based clinical hub.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Aix-Marseille Université is VB Tech's primary academic research partner. The university hosts the Institut de Neurosciences des Systèmes (INS), where The Virtual Brain technology was developed. CEO Serge De Senti is an associate professor at the university, and Lisa Otten serves at the interface of research and VB Tech. The university provides scientific talent, research infrastructure, and institutional credibility.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

INS is a research center within Inserm and Aix-Marseille University focused on brain dynamics and disorders like epilepsy. The Virtual Brain Technologies are based on research conducted at INS. Director Viktor Jirsa leads the institute, and Jan-Paul Triebkorn collaborates with VB Tech as INS personnel.

5Assistance Publique-Hôpitaux de Marseille (APHM)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The public hospital system of Marseille provides clinical research infrastructure and patient access. Prof. Fabrice Bartolomei leads the Epileptology department at APHM and co-founded VB Tech. APHM serves as Hub #0, the primary clinical reference center. APHM sponsors the EPINOV clinical trial.

virtualbraintech.com
Strategic tierCoreTypeTechnology or Integration
Description

Codemart is a software engineering firm based in Cluj-Napoca, Romania, specializing in neuroscience applications and open-source brain simulators. Lia Domide, Codemart's managing partner, leads all product development at VB Tech and developed The Virtual Brain platform.

7Centre national de la recherche scientifique (CNRS)
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

CNRS is France's largest public research organization. Listed as a partner with VB Tech, contributing to the scientific ecosystem supporting Virtual Brain technology development.

virtualbraintech.com
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

INSERM is a French public research institute dedicated to human health and medical science. INS hosts the Institut de Neurosciences des Systèmes where Virtual Brain research is conducted, and co-founder Viktor Jirsa serves as director.

9Hospices Civils de Lyon (HCL)
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

HCL of Lyon, represented by Prof. Sylvain Rheims, collaborates on the EPINOV clinical trial alongside APHM. One of 13 clinical centers participating in the largest epilepsy surgery clinical trial to date.

virtualbraintech.com
10EPINOV Consortium (13 Clinical Centers)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EPINOV is the largest clinical trial in epilepsy surgery to date, coordinated by Prof. Fabrice Bartolomei (APHM) and Prof. Sylvain Rheims (HCL Lyon), involving 13 leading clinical centers and 356 drug-resistant epilepsy patients. Validates VB Tech's VEP technology clinically.

virtualbraintech.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Viktor Jirsa is a key figure in EU flagships Human Brain Project and EBRAINS, which bridge neuroscience research and clinical application. These EU initiatives support the broader ecosystem of brain research that underpins VB Tech's technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Pixyl is an emerging AI neuroimaging vendor focused on multiple sclerosis and brain MRI analysis — overlapping with VB Tech's planned multiple sclerosis module and relevant as a focused AI-imaging competitor pursuing similar neurology indications.

TypeDirect peer
Description

Surgical Theater provides VR/3D surgical planning and visualization software used in neurosurgery — directly comparable to VB Tech's Virtual Surgery Simulation capability for pre-operative epilepsy resection planning and neurosurgical decision support.

TypeBroad incumbent
Description

Brainlab is an established incumbent in surgical planning, image-guided neurosurgery and radiotherapy software — a broader incumbent peer whose neurosurgery planning tools compete for hospital wallet alongside VB Tech's VEP module.

TypeDirect peer
Description

Perspectum builds quantitative MRI-based decision-support tools (e.g., LiverMultiScan, CoverScan) used in research and clinical care — a strong direct peer to VB Tech in multi-modal neuroimaging analytics for high-unmet-need neurological and chronic disease markets.

TypeBroad incumbent
Description

Siemens Healthineers is a global incumbent in neuroimaging scanners, PACS and AI imaging analytics (e.g., AI-Rad Companion) — relevant as the broader incumbent whose data, scanner and imaging AI footprint competes for the same hospital decision-makers VB Tech sells into.

TypeBroad incumbent
Description

GE HealthCare is a broad incumbent in MRI, PET, and AI-powered imaging analytics — comparable to VB Tech as an integrated imaging/imaging-AI provider selling into the same neurology and neurosurgery hospital customers.

7Nicolab
TypeDirect peer
Description

Nicolab (Stroke Viewer) is an AI imaging platform for time-critical neurovascular workflows — a relevant direct peer for VB Tech in clinical decision-support software that ingests multimodal neuroimaging (CT/MRI/EEG-style inputs) to inform acute treatment decisions.

TypeDirect peer
Description

RapidAI is an AI-based clinical decision-support platform for stroke and other neurovascular conditions, processing multimodal imaging to identify lesions and recommend interventions — directly comparable to VB Tech's positioning as imaging-driven SaMD for neurology.

TypeDirect peer
Description

Omniscient Neurotechnology (o8t / BrainKey) builds AI-powered brain mapping and connectomics software for clinical and research use — the closest direct competitor to VB Tech's Virtual Brain Twin and BrainXplore platform in patient-specific brain network modeling.

TypeOthers
Description

Codemart, VB Tech's core software development partner led by Lia Domide, is the external engineering organization building the Virtual Brain platform — included as an ecosystem peer because any investor should treat Codemart's bandwidth and VB Tech's reliance on it as a key vendor relationship.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VB-Tech

Computational Neuroscience Softwarevirtualbraintech.com

VB Tech (VB Tech S.A.S.) is a French deep-tech company developing patient-specific digital brain twins via its BrainXplore platform, serving academic neurosurgery centers and pharmaceutical partners — initially targeting drug-resistant epilepsy through its clinically validated VEP module.

What VB-Tech does

VB Tech S.A.S., headquartered in Aix-en-Provence, France, develops patient-specific digital brain twin technology for neurological and neurosurgical applications. The company's flagship product, BrainXplore, is a browser-based platform that ingests multimodal neuroimaging data (MRI, DTI, EEG, MEG, SEEG) and produces biophysically grounded whole-brain simulations using its exclusively licensed core engine, The Virtual Brain (TVB). Its lead clinical module, VEP (Virtual Epileptic Patient), provides clinical decision support for drug-resistant epilepsy by identifying epileptogenic zones with a 29% improvement over standard of care and enabling virtual surgery planning; the technology is currently being validated in the EPINOV trial, the largest epilepsy-surgery clinical study to date (13 centers, 356 patients), with an FDA submission in progress.

The company operates a Hub-model distribution strategy: leading academic medical centers (APHM Marseille as Hub #0, UPMC Pittsburgh as Hub #1, UC Davis as Hub #3) install BrainXplore on-premises, receive training, and serve as clinical reference sites for research and investigational use. The current revenue posture is largely pre-commercial: Hubs receive free research access, monetizable streams are expected to come from software subscriptions, clinical module licensing (VEP), pharma partnership services for Alzheimer/Parkinson's/M/S/schizophrenia, and the BrainXplore Clinical Fellowship Program. Leadership combines academic founders (CSO Prof. Viktor Jirsa, EPINOV lead Prof. Fabrice Bartolomei) with industrial scale-up operators (CEO Serge De Senti from January 2026, Deputy CEO Jean-Marc Ferrier, CTO Eric Guiffard, CGO Philippe Schulz), and the company has only one disclosed external capital event — a $519,167 round from Rise Partners in January 2025.

VB-Tech firmographics

Firmographics
Name
VB-Tech
Legal name
VB Tech S.A.S.
Website
https://virtualbraintech.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
VB Tech (VB Tech S.A.S.) is a French deep-tech company developing patient-specific digital brain twins via its BrainXplore platform, serving academic neurosurgery centers and pharmaceutical partners — initially targeting drug-resistant epilepsy through its clinically validated VEP module.
Ownership category
akta.pro rank

VB-Tech industry classification

Industry
Product category
Computational Neuroscience Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Digital brain twin
  • Neurological simulation software
  • Epilepsy surgery planning
  • Computational neuroscience platform
  • Patient-specific brain modeling

Where VB-Tech is headquartered

Location

Headquarters

HQ city
Marseille
HQ country
France
HQ region
Europe

Offices4 records

Markets served

VB-Tech business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Platform Licensing (BrainXplore): BrainXplore platform offered for research, education, and investigational clinical studies. Hubs receive free access for research. Revenue model likely centers on software licensing/subscription for clinical deployment post-regulatory validation.
  2. Clinical Module Licensing (VEP Module): VEP (Virtual Epileptic Patient) module designed as a clinical decision-support tool for neurosurgical planning in drug-resistant epilepsy. Expected to generate revenue through clinical licensing as regulatory approval is obtained.
  3. Pharmaceutical Industry Partnerships: Clinical modules for other brain diseases (Alzheimer's, Parkinson's, M/S, Schizophrenia) to be developed in partnership with pharmaceutical industry to support precision drug development.
  4. Clinical Fellowship Program: BrainXplore Clinical Fellowship Program — an immersive experience for neurologists, neurosurgeons, and researchers, with 5 fellowship slots remaining through end of 2026.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

VB-Tech product offering

Product offering

Core offering

VB Tech provides the BrainXplore platform, a browser-based system that generates patient-specific digital brain twins from multimodal neuroimaging data (MRI, DTI, EEG, SEEG, MEG) to simulate whole-brain dynamics. The platform's first clinical module, the Virtual Epileptic Patient (VEP), supports surgical planning for drug-resistant epilepsy by identifying epileptogenic zones and enabling virtual testing of resection strategies before surgery. Additional clinical modules for Alzheimer's, Parkinson's, multiple sclerosis, and schizophrenia are in development in partnership with pharmaceutical companies.

Product overview

VB Tech provides a modular brain simulation platform centered on BrainXplore, a browser-based platform that generates patient-specific digital brain twins from multimodal neuroimaging data. The core Virtual Brain Twin technology simulates whole-brain dynamics. The VEP (Virtual Epileptic Patient) module targets drug-resistant epilepsy for surgical planning. Additional modules for Alzheimer's, Parkinson's, M/S, and schizophrenia are in development in partnership with pharmaceutical industry for precision drug development.

Differentiator

Problem solved

Functional benefit

Brands

  • VEP – Virtual Epileptic Patient™: Clinical decision-support module for patients with drug-resistant epilepsy that simulates the propagation of epileptic activity across the brain network using patient-specific neuroimaging and intracranial EEG data.
  • BrainXplore™

Products and services

  • BrainXplore Platform Browser-based digital brain twin platform that generates patient-specific virtual brain models from multimodal neuroimaging data. Provides automated preprocessing, personalized whole-brain simulations, advanced inference modules, and an interactive 3-D viewer for clinicians and researchers in neurology and neuroscience.
  • VEP - Virtual Epileptic Patient Module Clinical decision-support module for drug-resistant epilepsy patients that uses patient-specific neuroimaging and intracranial EEG (SEEG) data to simulate epileptic activity propagation across the brain network. Identifies epileptogenic zones by comparing simulated seizure dynamics to recorded data and enables virtual testing of resection strategies before surgery.

Quantifiable outcome

  • 29% improvement in identification of epileptogenic zones vs standard methods (retrospective study on 53 patients)
  • +4 more outcomes

Companies that use VB-Tech

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles2 records

VB-Tech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature9 records

VB-Tech partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core, secondary and minor.

  • UPMC (University of Pittsburgh Medical Center)coreChannel Partner/ Reseller/ Distributor · 7 March 2025UPMC Pittsburgh is Hub #1, an official BrainXplore ambassador. VB Tech installed the BrainXplore platform and trained clinicians and researchers to use it in daily workflows. Led by Jorge A. González-Martínez, MD, PhD. Represents VB Tech's US market entry.
  • UC DaviscoreChannel Partner/ Reseller/ Distributor · 7 March 2025UC Davis is Hub #3, an official BrainXplore ambassador. VB Tech installed the BrainXplore platform and trained clinicians and researchers to use it in daily workflows. Led by Nigel Paul Pedersen, MD. Second US-based clinical hub.
  • Aix-Marseille UniversitécoreStrategic or Co-development Partner · 1 January 2021Aix-Marseille Université is VB Tech's primary academic research partner. The university hosts the Institut de Neurosciences des Systèmes (INS), where The Virtual Brain technology was developed. CEO Serge De Senti is an associate professor at the university, and Lisa Otten serves at the interface of research and VB Tech. The university provides scientific talent, research infrastructure, and institutional credibility.
  • Institut de Neurosciences des Systèmes (INS)coreStrategic or Co-development PartnerINS is a research center within Inserm and Aix-Marseille University focused on brain dynamics and disorders like epilepsy. The Virtual Brain Technologies are based on research conducted at INS. Director Viktor Jirsa leads the institute, and Jan-Paul Triebkorn collaborates with VB Tech as INS personnel.
  • Assistance Publique-Hôpitaux de Marseille (APHM)coreStrategic or Co-development PartnerThe public hospital system of Marseille provides clinical research infrastructure and patient access. Prof. Fabrice Bartolomei leads the Epileptology department at APHM and co-founded VB Tech. APHM serves as Hub #0, the primary clinical reference center. APHM sponsors the EPINOV clinical trial.
  • CodemartcoreTechnology or IntegrationCodemart is a software engineering firm based in Cluj-Napoca, Romania, specializing in neuroscience applications and open-source brain simulators. Lia Domide, Codemart's managing partner, leads all product development at VB Tech and developed The Virtual Brain platform.
  • Centre national de la recherche scientifique (CNRS)secondaryStrategic or Co-development PartnerCNRS is France's largest public research organization. Listed as a partner with VB Tech, contributing to the scientific ecosystem supporting Virtual Brain technology development.
  • Institut National de la Santé et de la Recherche Médicale (INSERM)secondaryStrategic or Co-development PartnerINSERM is a French public research institute dedicated to human health and medical science. INS hosts the Institut de Neurosciences des Systèmes where Virtual Brain research is conducted, and co-founder Viktor Jirsa serves as director.
  • Hospices Civils de Lyon (HCL)secondaryStrategic or Co-development PartnerHCL of Lyon, represented by Prof. Sylvain Rheims, collaborates on the EPINOV clinical trial alongside APHM. One of 13 clinical centers participating in the largest epilepsy surgery clinical trial to date.
  • EPINOV Consortium (13 Clinical Centers)coreStrategic or Co-development PartnerEPINOV is the largest clinical trial in epilepsy surgery to date, coordinated by Prof. Fabrice Bartolomei (APHM) and Prof. Sylvain Rheims (HCL Lyon), involving 13 leading clinical centers and 356 drug-resistant epilepsy patients. Validates VB Tech's VEP technology clinically.
  • Human Brain Project / EBRAINSminorStrategic or Co-development PartnerViktor Jirsa is a key figure in EU flagships Human Brain Project and EBRAINS, which bridge neuroscience research and clinical application. These EU initiatives support the broader ecosystem of brain research that underpins VB Tech's technology.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

VB-Tech competitors and assessment

Company assessment

Emerging players

  • Pixyl: Pixyl is an emerging AI neuroimaging vendor focused on multiple sclerosis and brain MRI analysis — overlapping with VB Tech's planned multiple sclerosis module and relevant as a focused AI-imaging competitor pursuing similar neurology indications.

Direct peers

  • Surgical Theater: Surgical Theater provides VR/3D surgical planning and visualization software used in neurosurgery — directly comparable to VB Tech's Virtual Surgery Simulation capability for pre-operative epilepsy resection planning and neurosurgical decision support.
  • Perspectum: Perspectum builds quantitative MRI-based decision-support tools (e.g., LiverMultiScan, CoverScan) used in research and clinical care — a strong direct peer to VB Tech in multi-modal neuroimaging analytics for high-unmet-need neurological and chronic disease markets.
  • Nicolab: Nicolab (Stroke Viewer) is an AI imaging platform for time-critical neurovascular workflows — a relevant direct peer for VB Tech in clinical decision-support software that ingests multimodal neuroimaging (CT/MRI/EEG-style inputs) to inform acute treatment decisions.
  • RapidAI: RapidAI is an AI-based clinical decision-support platform for stroke and other neurovascular conditions, processing multimodal imaging to identify lesions and recommend interventions — directly comparable to VB Tech's positioning as imaging-driven SaMD for neurology.
  • Omniscient Neurotechnology: Omniscient Neurotechnology (o8t / BrainKey) builds AI-powered brain mapping and connectomics software for clinical and research use — the closest direct competitor to VB Tech's Virtual Brain Twin and BrainXplore platform in patient-specific brain network modeling.

Broad incumbents

  • Brainlab: Brainlab is an established incumbent in surgical planning, image-guided neurosurgery and radiotherapy software — a broader incumbent peer whose neurosurgery planning tools compete for hospital wallet alongside VB Tech's VEP module.
  • Siemens Healthineers: Siemens Healthineers is a global incumbent in neuroimaging scanners, PACS and AI imaging analytics (e.g., AI-Rad Companion) — relevant as the broader incumbent whose data, scanner and imaging AI footprint competes for the same hospital decision-makers VB Tech sells into.
  • GE HealthCare: GE HealthCare is a broad incumbent in MRI, PET, and AI-powered imaging analytics — comparable to VB Tech as an integrated imaging/imaging-AI provider selling into the same neurology and neurosurgery hospital customers.

Others

  • Codemart: Codemart, VB Tech's core software development partner led by Lia Domide, is the external engineering organization building the Virtual Brain platform — included as an ecosystem peer because any investor should treat Codemart's bandwidth and VB Tech's reliance on it as a key vendor relationship.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

VB-Tech social profiles

Digital presence

VB-Tech compliance and trust

Trust signal

Compliance2 records

VB-Tech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VB-Tech leadership team

Management profile

Number of profiles

Profiles13 records

VB-Tech funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VB-Tech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VB-Tech

What does VB-Tech do?

VB Tech provides the BrainXplore platform, a browser-based system that generates patient-specific digital brain twins from multimodal neuroimaging data (MRI, DTI, EEG, SEEG, MEG) to simulate whole-brain dynamics. The platform's first clinical module, the Virtual Epileptic Patient (VEP), supports surgical planning for drug-resistant epilepsy by identifying epileptogenic zones and enabling virtual testing of resection strategies before surgery. Additional clinical modules for Alzheimer's, Parkinson's, multiple sclerosis, and schizophrenia are in development in partnership with pharmaceutical companies.

Is VB-Tech a public or private company?

VB-Tech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was VB-Tech founded?

VB-Tech was founded in 2021. It employs 1 to 10 people.

Where is VB-Tech based?

VB-Tech is headquartered in Marseille, France, in the Europe region.

How does VB-Tech make money?

Four revenue lines are on record. Software Platform Licensing (BrainXplore) is the primary driver. The others are clinical Module Licensing (VEP Module), pharmaceutical Industry Partnerships and clinical Fellowship Program.

Who are VB-Tech's main competitors?

Pixyl is listed as an emerging player. Direct peers are Surgical Theater, Perspectum, Nicolab, RapidAI and Omniscient Neurotechnology. Broad incumbents are Brainlab, Siemens Healthineers and GE HealthCare. Codemart is listed as an others.

Does VB-Tech have an API?

No public API is recorded for VB-Tech.

What industry is VB-Tech in?

VB-Tech's product category is Computational Neuroscience Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital). Its NAICS code is 54151 and its SIC code is 7373.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales